Anti-Nav1.7 antibody [N68/6]
4
(1 Review)
|
(15 Publications)
Mouse Monoclonal SCN9A antibody. Suitable for IHC-P and reacts with Mouse samples. Cited in 15 publications.
View Alternative Names
NENA, SCN9A, Sodium channel protein type 9 subunit alpha, Neuroendocrine sodium channel, Peripheral sodium channel 1, Sodium channel protein type IX subunit alpha, Voltage-gated sodium channel subunit alpha Nav1.7, hNE-Na, PN1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nav1.7 antibody [N68/6] (AB85015)
ab85015 at 1/100 dilution staining Nav1.7 in mouse back skin tissue section by IHC-P. Bouin's fixed and paraffin-embedded tissue sections were used. Tissue underwent heat mediated antigen retrieval in microwave with two, 5 minutes incubation intervals in citrate buffer. A Fluorophore conjugated goat anti mouse at 1/50 dilution was used as secondary.
Reactivity data
Product details
The clone number has been updated from S68-6 to N68/6, both clone numbers name the same antibody clone.
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Nav1.7 acts as an essential component in neuronal excitability. It is not part of a larger protein complex but operates as an individual unit within the cell membrane. By allowing sodium ions to enter the neuron Nav1.7 contributes to the depolarization phase of action potentials. This function is critical in the propagation of electrical signals in the nervous system specifically in nociceptive neurons that are involved in pain sensation.
Pathways
Nav1.7 is integral to the nociceptive pain pathway. It works with other sodium channels such as Nav1.8 which also play roles in pain sensation. Nav1.7's activity helps to initiate and maintain action potentials facilitating the transmission of pain signals to the central nervous system. Additionally Nav1.7 is linked to neuropathic pain pathways where its function underpins the continuous firing of neurons even in the absence of external stimuli.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Cancers 15: PubMed37345144
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 16:1091096 PubMed36937049
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 16:1039957 PubMed36733665
2023
Applications
Unspecified application
Species
Unspecified reactive species
Pain 164:1718-1733 PubMed36727909
2023
Applications
Unspecified application
Species
Unspecified reactive species
Neurobiology of pain (Cambridge, Mass.) 12:100109 PubMed36531612
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular pharmaceutics : PubMed33404254
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 46:782-794 PubMed32468069
2020
Applications
Unspecified application
Species
Unspecified reactive species
EJNMMI research 10:49 PubMed32409881
2020
Applications
Unspecified application
Species
Unspecified reactive species
Channels (Austin, Tex.) 14:69-78 PubMed32089065
2020
Applications
Unspecified application
Species
Unspecified reactive species
Bioconjugate chemistry 30:2879-2888 PubMed31647222
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com